Cargando…
COVID-19 and acute kidney injury in pediatric subjects: is there a place for eculizumab treatment?
Autores principales: | Trimarchi, Hernán, Coppo, Rosanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523686/ https://www.ncbi.nlm.nih.gov/pubmed/32996110 http://dx.doi.org/10.1007/s40620-020-00859-1 |
Ejemplares similares
-
Eculizumab, SARS-CoV-2 and atypical hemolytic uremic syndrome
por: Trimarchi, Hernán, et al.
Publicado: (2020) -
Crescents and IgA Nephropathy: A Delicate Marriage
por: Trimarchi, Hernán, et al.
Publicado: (2022) -
Eculizumab treatment for renal failure in a pediatric patient with COVID-19
por: Mahajan, Ruchi, et al.
Publicado: (2020) -
Acute peritoneal dialysis in the treatment of COVID-19-related acute kidney injury
por: Ponce, Daniela, et al.
Publicado: (2020) -
H1N1 infection and acute kidney injury in the critically ill
por: Trimarchi, Hernan, et al.
Publicado: (2009)